コンテンツへスキップ
Merck

CRISPR31

Sigma-Aldrich

CRISPR Non-Target Negative Control Plasmid for Bacteria

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
41106617
NACRES:
NA.51

現在、価格および在庫状況を閲覧できません。

形状

liquid

包装

vial of 50 μL

濃度

20 ng/μL in TE buffer; DNA (1μg of purified plasmid DNA)

テクニック

microbiological culture: suitable

アプリケーション

CRISPR
genome editing

プロモーター


Promoter activity: constitutive

輸送温度

dry ice

保管温度

−20°C

詳細

Recent publications using CRISPR/Cas9-mediated recombineering in E. coli tout editing efficiencies near 100%[1], making CRISPR/Cas9-mediated recombineering the most powerful bacterial genome engineering method to date. In addition, Cas9-mediated recombineering overcomes the dependence on a second recombination step, avoids the creation of destabilizing scar sites, can be used in multiplexing, and is less time-consuming than previous protocols[2].

Here we present a novel dual-vector CRISPR/Cas-mediated λ-Red system for improved recombineering in E. coli. Our system is shown to facilitate homology-directed repair of DSBs created by Cas9 endonuclease, enabling genetic alterations through chromosomal integration of a donor DNA.

This plasmid is to be used in combination with the Cas9 Lambda Red homologous recombination plasmid for E. coli (CAS9BAC1P) as the negative control for your custom gene editing experiment. The custom gRNA (CRISPRBACD) can be designed and ordered through https://www.sigmaaldrich.com/pc/ui/genomics-home/customcrispr

The CRISPR Non-Target Negative Control Plasmid for Bacteria (CRISPR31) contains a non-targeting spacer expressed constitutively from a J23119 promoter, a ampicillin resistance marker, a pBR322 origin of replication, and a sacB gene from Bacillus subtilis for counter-selection-based curing.

アプリケーション

Bacterial Genome Editing
  • HR-mediated recombineering for mutation or SNP analysis
  • Creation of HR-mediated knock-in cell lines with promoters, fusion tags, or reporters integrated into endogenous genes
  • Creation of gene knockouts in E. coli cell lines
Metabolic Engineering
Strain Optimization

特徴および利点

Efficient: increased efficiency of HR-mediated integration
Markerless: does not require antibiotic resistance marker insertion
Scarless: no scar sequences from marker excision which often cause off-target recombination
Multiplexing: multiple custom gRNA sequences can be used at a time

原理

CRISPR/Cas systems are employed by bacteria and archaea as a defense against invading viruses and plasmids. Recently, the type II CRISPR/Cas system from the bacterium Streptococcus pyogenes has been engineered to function using two molecular components: a single Cas9 protein and a non-coding guide RNA (gRNA). The Cas9 endonuclease can be programmed with a single or dual gRNA, directing a DNA double-strand break (DSB) at a desired genomic location. Nuclease-based methods are largely toxic when employed as microbial gene editing tools because many bacteria lack the necessary DNA repair mechanisms found in eukaryotic systems. However, when CRISPR/Cas9 is used to mediate recombineering, this cytotoxic quality offers an advantage in that Cas9-induced double stranded breaks kill cells that do not recombine with the donor DNA. This provides an inherent method of selection for markerless, scarless gene editing that is dramatically more efficient and more amenable to multiplexing than traditional methods. The E. coli HR negative control plasmid (Catalog Number CRISPR31-1UG) contains a gRNA sequence targeting no known genomic DNA seqeuence in Wild-type E. Coli. This makes it suitable for use a negative control when used in conjunction with CAS9BAC1P-1UG.

保管分類コード

12 - Non Combustible Liquids

WGK

WGK 2

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

CRISPR31-1EA:
CRISPR31-BULK:


  • 試験成績書(COA)

    製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

    COA(試験成績書)のサンプル

    これはCOAのサンプルであり、この製品の最近製造されたロットを示すものではありません。

    以前この製品を購入いただいたことがある場合

    文書ライブラリで、最近購入した製品の文書を検索できます。

    文書ライブラリにアクセスする

    Yifan Li et al.
    Metabolic engineering, 31, 13-21 (2015-07-05)
    Engineering cellular metabolism for improved production of valuable chemicals requires extensive modulation of bacterial genome to explore complex genetic spaces. Here, we report the development of a CRISPR-Cas9 based method for iterative genome editing and metabolic engineering of Escherichia coli.
    Michael E Pyne et al.
    Applied and environmental microbiology, 81(15), 5103-5114 (2015-05-24)
    To date, most genetic engineering approaches coupling the type II Streptococcus pyogenes clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system to lambda Red recombineering have involved minor single nucleotide mutations. Here we show that procedures for carrying out more complex

    資料

    In this article, we present an application of our novel E. coli CRISPR/Cas-mediated Lambda-Red (λ-Red) homologous recombination (HR) vector system, which facilitates gene editing through the homology-directed repair (HDR) of double-stranded DNA breaks (DSBs) created by Cas9 endonuclease, using either ssDNA or dsDNA as an editing template.

    ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

    製品に関するお問い合わせはこちら(テクニカルサービス)